来自黑色素瘤的不可切除的心脏转移对组合免疫疗法反应良好 - 一份病例报告
Ek Leone Oh1, Peter Dias2,3, Zeyad Al-Ogaili4
1Medical Oncology Department, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA 6150, Australia.
European heart journal. Case reports
|June 13, 2024
概括
黑色素瘤引起的症状性心脏转移是罕见的,但可以通过免疫疗法有效治疗. 这种方法为管理不可切除的心脏瘤提供了一个有希望的选择.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 黑色素瘤转移到包括心脏在内的遥远器官是不常见的.
- 黑色素瘤引起的症状性心脏转移是一个罕见的临床挑战.
- 对心脏黑色素瘤转移的最佳管理策略尚未明确,特别是免疫治疗的进步.
相关概念视频
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K